Thrilled to have started my PhD in Mental Health Science this week at @UCL, supported by @wellcometrust. Excited for the journey ahead and grateful to be part of such an innovative and supportive program!
It was great to visit the fantastic @healthshopnottm with @pwidpride as part of the @safe_pipe project today and hear what people thought of the intervention. Paraphernalia laws are non-sensical at the moment and require change!
@lshtm media with @safe_pipe today for filming & focus group! Great to visit our amazing project partner @healthshopnottm, chat with people about their experiences with the crack pipes & how we can do better. Pics - SIPP team, not our expert group members 😉
@iHOSTstudy launch @ St James! Before: inpatient not on community OST, or script not confirmed: dihydrocodiene only. Now: 20mgs methadone PRN, full dose when confirmed. Together, improving care for PWUD. Just a start. Thank you team & @LeedsHospitals.
The @PMCPAUK's decision on @Ethypharm naloxone posters is truly tragic.
In the middle of a public health crisis, we need all the tools and info possible to prevent more deaths.
Removing public images for overdose awareness is harmful for everyone.
pmcpa.org.uk/cases/completed…
🔔 New Publication Alert 🔔
“Wastewater-based monitoring of the nitazene analogues: First detection of protonitazene in wastewater” now available in @SciTotEnv from @Rtdnb and collaborators. Check it out ⬇️
🔗: doi.org/10.1016/j.scitotenv.…
The ACMD has released updated workstreams for 2024. We are excited to see that they have self-commissioned a workstream on improving the tracking of ACMD recommendations. It's great to see recommendation 5 from our report "Empowering the ACMD" implemented. static1.squarespace.com/stat…
🚨 New Report Alert! 🚨 Read our analysis on "Naloxone: Legal Challenges and Life-Saving Opportunities" in the battle against opioid deaths. Get it here: drugpolicycentre.org/s/Nalox…#Naloxone
BREAKING: ACMD barriers to research part 2 report released. After years of our advocacy, HMG set to address research barriers for Schedule 1 drugs. Recommendations though are limited in scope and short of a significant advance, notably patient access 1/n
gov.uk/government/publicatio…
ONS data debunks the notion of cocaine as a rich person's drug. Roughly 2% across income brackets (from <£10,400 to >£52,000) use it, with highest prevalence in the lowest and highest brackets.
Decriminalization is a harm reduction measure, and therefore must be implemented along side other complementary measures to support PWUD. No measure on its own is effective enough
15 new synthetic opioids made Class A drugs "as the Govt continues to act to prevent drug deaths"
Given the history of other class A's, it's delusional to imagine more prohibitions can meaningfully address the drug death crisis
1/
gov.uk/government/news/fifte…
As a hopefully welcome interruption from the riotous IIT discourse on your timeline; my FIRST preprint is out now! Let’s take a minute to think about how the brain does time : biorxiv.org/content/10.1101/… 🧵 1/14
The ACMD is the UK's expert body advising government on drug policy.
It's notably the first statute in the Misuse of Drugs Act 1971, underscoring its intended key role in policy design.
Yet its influence has been gradually diminishing. Our new report explores these issues. 🧵
New pre-print🚨with the amazing @danieljamesyon @cdfrith
We put a Bayesian spin on the classic comparator model of sense of agency; showing how simple gain control mechanisms can account for conterintuitive effects of priors on perception👇
We show that #wellbeing (🥰🤣) is a whole brain process (🧠), with individual differences supported by separable sets of co-active embodied self- (🩷), narrative self- (🗣️), and visual-attention- (👁️) related brain networks: biorxiv.org/content/10.1101/…